FDA Inspection
Central Pennsylvania Blood Bank HeadquartersCentral Pennsylvania Blood Bank Headquarters – FDA Inspection, Mar 13, 2014
Record Details
This FDA Inspection record concerns Central Pennsylvania Blood Bank Headquarters, with an inspection on March 13, 2014, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- March 13, 2014
- Product Type
- Biologics
View Company Profile
ID · 501e5d02-46ef-45fa-8ef6-d981fee5c91a
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 869762
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of Central Pennsylvania Blood Bank Headquarters
6| Date | Classification | Office | Project area |
|---|---|---|---|
| October 19, 2023 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 1, 2022 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| August 14, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 26, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 22, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Central Pennsylvania Blood Bank Headquarters
- FDA Inspection 1222397 - 2023-10-19
- FDA Inspection 1179906 - 2022-09-01
- FDA Inspection 1068986 - 2018-08-14
- FDA Inspection 961421 - 2016-02-26
- FDA Inspection 773412 - 2012-03-22
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.